tiamulin hydrogen fumarate
abbey laboratories pty ltd - tiamulin as tiamulin hydrogen fumarate - unknown - tiamulin as tiamulin hydrogen fumarate antibiotic active 0.0 - active constituent
tiamulin fumarate
dox-al australia pty ltd - tiamulin as tiamulin hydrogen fumarate - unknown - tiamulin as tiamulin hydrogen fumarate antibiotic active 0.0 - active constituent
tiamulin hydrogen fumarate
abbey laboratories pty ltd - tiamulin as tiamulin hydrogen fumarate - unknown - tiamulin as tiamulin hydrogen fumarate antibiotic active 0.0 - active constituent
tiamvet 125 mg/ml solução oral
ceva santé animale - tiamulin 10.12 mg/ml - oral solution - chicken, pigs, turkeys - tiamulin
vetmulin 162 mg/ml solution for injection for pigs
huvepharma nv - tiamulin - solution for injection - 162 milligram(s)/millilitre - tiamulin - porcine - antibacterial
denagard 10% coated premix
elanco malaysia sdn bhd - tiamulin hydrogen fumarate -
altabax- retapamulin ointment
physicians total care, inc. - retapamulin (unii: 4mg6o8991r) (retapamulin - unii:4mg6o8991r) - retapamulin 10 mg in 1 g - altabax is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm2 in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to staphylococcus aureus (methicillin-susceptible isolates only) or streptococcus pyogenes [see clinical studies (14)] . to reduce the development of drug-resistant bacteria and maintain the effectiveness of altabax and other antibacterial drugs, altabax should none. pregnancy category b . effects on embryo-fetal development were assessed in pregnant rats given 50, 150, or 450 mg/kg/day by oral gavage on days 6 to 17 postcoitus. maternal toxicity (decreased body weight gain and food consumption) and developmental toxicity (decreased fetal body weight and delayed skeletal ossification) were evident at doses ≥150 mg/kg/day. there were no treatment-related malformations observed in fetal rats. retapamulin was given as a continuous intravenous infusion to pregnan
bimagard 12.5%- tiamulin fumarate liquid
bimeda, inc. - tiamulin fumarate (unii: ion1q02zcx) (tiamulin - unii:e38wz4u54r) - indications: bimagard™ 12.5% (tiamulin hydrogen fumarate), when administered in the drinking water for five consecutive days, is an effective antibiotic for the treatment of swine dysentery associated with brachyspira (formerly serpulina or treponema ) hyodysenteriae susceptible to tiamulin at a dose level of 3.5 mg tiamulin hydrogen fumarate per pound of body weight daily and for treatment of swine pneumonia due to actinobacillus pleuropneumoniae susceptible to tiamulin when given at 10.5 mg tiamulin hydrogen fumarate per pound of body weight daily. contraindications: swine being treated with bimagard™ 12.5% (tiamulin hydrogen fumarate) should not have access to feeds containing polyether ionophores (e.g. monensin, lasalocid, narasin, salinomycin and semduramicin) as adverse reactions may occur.
tiamulin fumarate powder
sel biochem xinjiang co., ltd. - tiamulin fumarate (unii: ion1q02zcx) (tiamulin - unii:e38wz4u54r) -
tiamulin fumarate powder
jiangsu sel biochem co., ltd. - tiamulin fumarate (unii: ion1q02zcx) (tiamulin - unii:e38wz4u54r) -